We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Other Articles |

Evaluation of Drug Therapy: Proceedings of the Symposium on Evaluation of Drug Therapy in Neurologic and Sensory Diseases

Norman DeNosaquo, M.D.
JAMA. 1962;179(7):584-585. doi:10.1001/jama.1962.03050070106028.
Text Size: A A A
Published online


The National Advisory Neurological Diseases and Blindness Council is to be commended for sponsoring this 2-day conference which examined the problems of drug therapy evaluation. The program was planned around 4 half-day sessions, the first of which considered the problems of testing from the point of view of a pharmacologist, a representative of the pharmaceutical industry, a representative of the Food and Drug Administration, and several biostatisticians. The second and third sessions consisted of the meetings of the 8 special panels which considered such items as epilepsy, vertigo, neuralgias and neuropathies, headache, glaucoma and Parkinsonism. The last general session heard reports by the panel chairmen on the results of their deliberations and closed with a summation by Dr. Francis M. Forster, the general chairman.

The general outline for testing programs was presented by the biostatisticians and touched on such items as the number of patients needed for a study, double


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.